"Head and Neck Cancer Experts from Around the World Gather"... Share Latest Treatments in Immunotherapy and Precision Medicine
ICHNO 2026 to Be Held in Suwon on November 26-27
Experts from South Korea and Abroad, Including the United States, Japan and Singapore, to Attend
Head and neck cancer experts from around the world will gather to share the latest treatment strategies and research findings.
The Korean Society of Head and Neck Oncology said it will hold its international academic conference, "ICHNO 2026," on November 26-27 at the Suwon Convention Center in Suwon, Gyeonggi Province. Now in its third year, the event will bring together experts from South Korea, the United States, Japan, Singapore, Taiwan and Australia to discuss advances in the treatment of head and neck cancer, including immunotherapy, precision medicine and the latest surgical techniques.
On the first day of the conference, Professor Patrick Ha and Professor Sue Sun Yom of the University of California in the United States will present the latest treatment trends for salivary gland cancer and treatment strategies for patients with head and neck cancer who have difficulty undergoing conventional chemotherapy-based treatment, respectively. Professor Jongcheol Park of Dana-Farber Cancer Institute and Harvard Medical School will then discuss new treatment strategies using existing cancer therapy targets and the potential for developing new drugs. Professor Jatin Shah of Memorial Sloan Kettering Cancer Center will review advances in head and neck cancer surgery over the past 50 years and look ahead to its future.
Professor Seiichi Yoshimoto of Japan's National Cancer Center Hospital will discuss treatment strategies for head and neck sarcomas, while Professor Melvin Lee Kiang Chua of Singapore's National Cancer Centre will explain precision treatment strategies for nasopharyngeal cancer in the era of immunotherapy.
The second day will cover a range of topics, including systemic treatment and precision medicine for rare head and neck cancers, as well as reconstructive surgery. Professor Hyunseok Kang of Stanford University School of Medicine in the United States will discuss systemic treatment options for patients with rare head and neck cancers for whom surgery and radiation therapy alone are insufficient. Professor Tsung-Lin Yang of National Taiwan University will present on the relationship between tumor satellite metastases, which are involved in tumor invasion and metastasis, and the aggressiveness of head and neck cancer.
Professor Soon-hyun Ahn of Seoul National University College of Medicine will discuss treatment strategies that take into account long-term functional outcomes in hypopharyngeal cancer, while Professor Jong-woo Choi of the University of Ulsan College of Medicine will present on the potential for advances in reconstructive microsurgery for facial and head and neck tumors.
In the field of thyroid cancer surgery, Professor Kyriakos Vamvakidis of Greece will discuss the clinical value and importance of intraoperative nerve monitoring. Professor Sydney Ch'ng of the University of Sydney in Australia will present a new approach to breaking down the divide between aesthetic considerations and functional reconstruction in head and neck reconstructive surgery.
In addition, during the "Meet the Experts" session, Professor Natalie Silver of the Cleveland Clinic in the United States will discuss the development of ribonucleic acid (RNA) therapies for head and neck and thyroid cancers and their potential clinical applications. Professor Hang-seok Jang of Yonsei University College of Medicine will share his experience with surgical treatment for recurrent and advanced thyroid cancer, while Professor Jin-hyung Kang of the Catholic University of Korea College of Medicine will present research on the oral cancer microbiome and tumor immune environment, as well as precision medicine using liquid biopsies.
In the field of surgery, Professor Kyung Tae of Hanyang University College of Medicine will discuss advances and clinical expertise in transoral robotic thyroid surgery. Professor Sheng-Po Hao of Fu Jen Catholic University in Taiwan will share the principles and clinical approaches of minimally invasive endoscopic head and neck surgery.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Kim Cheol-ho, president of the Korean Society of Head and Neck Oncology, said, "This conference will be a forum for multidisciplinary academic exchange, covering not only surgical treatment but also radiation, drug and immunotherapies, as well as reconstruction. We expect the latest research findings from world-renowned experts and the extensive clinical experience of South Korean medical professionals to come together and prompt wide-ranging discussions on the diagnosis and treatment of head and neck cancer and patient-tailored treatment strategies."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.